132 related articles for article (PubMed ID: 36716490)
1. Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT.
Li S; Wang H; Wang G; Lu X; Yang J
Clin Nucl Med; 2023 May; 48(5):445-447. PubMed ID: 36716490
[TBL] [Abstract][Full Text] [Related]
2. B-cell peripheral neurolymphomatosis: MRI and
DeVries AH; Howe BM; Spinner RJ; Broski SM
Skeletal Radiol; 2019 Jul; 48(7):1043-1050. PubMed ID: 30666391
[TBL] [Abstract][Full Text] [Related]
3. Diffuse Large B-Cell Lymphoma Recurring as Neurolymphomatosis on FDG PET/CT.
Ganeshalingam R; Roach P; Schembri GP
Clin Nucl Med; 2019 Feb; 44(2):145-147. PubMed ID: 30516683
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of nasal type NK/T cell lymphoma presenting as neurolymphomatosis on 18F-FDG PET/CT: A case report and literature review.
Pan Q; Luo Y
Medicine (Baltimore); 2020 Jan; 99(1):e18640. PubMed ID: 31895825
[TBL] [Abstract][Full Text] [Related]
5.
Ruff A; Ballard HJ; Pantel AR; Namoglu EC; Hughes ME; Nasta SD; Chong EA; Bagg A; Ruella M; Farwell MD; Svoboda J; Sellmyer MA
Mol Imaging Biol; 2021 Dec; 23(6):818-826. PubMed ID: 34231105
[TBL] [Abstract][Full Text] [Related]
6. Early Hyperprogression of Lymphoma Detected by 18 F-FDG PET/CT After Chimeric Antigen Receptor T-Cell Therapy.
He L; Deng Y; Deng Y; Xie H; Zhang W
Clin Nucl Med; 2023 Mar; 48(3):256-258. PubMed ID: 36634320
[TBL] [Abstract][Full Text] [Related]
7. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy].
Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941
[TBL] [Abstract][Full Text] [Related]
8. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M
Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
[TBL] [Abstract][Full Text] [Related]
9. New Onset of Tuberculosis Complicating FDG PET/CT Evaluation in Patient With Recent Chimeric Antigen Receptor T-Cell Therapy.
Wang G; Yang X; Wang H; Wang W; Yang J
Clin Nucl Med; 2023 Jul; 48(7):647-649. PubMed ID: 37083630
[TBL] [Abstract][Full Text] [Related]
10.
Chague P; Phan CM; Lapusan S; Zhang-Yin J; Cottereau AS
Diagn Interv Imaging; 2019 Sep; 100(9):527-528. PubMed ID: 30853415
[No Abstract] [Full Text] [Related]
11. Lumbosacral Plexus Neurolymphomatosis: A Typical 18FDG PET/CT Pattern to Recognize.
Bordeau K; Eberlé MC; Fabbro M; Fersing C; Deshayes E
Clin Nucl Med; 2022 Apr; 47(4):352-353. PubMed ID: 34739401
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.
Georgi TW; Kurch L; Franke GN; Jentzsch M; Schwind S; Perez-Fernandez C; Petermann N; Merz M; Metzeler K; Borte G; Hoffmann S; Herling M; Denecke T; Kluge R; Sabri O; Platzbecker U; Vučinić V
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6131-6138. PubMed ID: 36662305
[TBL] [Abstract][Full Text] [Related]
13.
Tan X; Sun X; Yuan H; He L; Ding C; Jiang L
Hell J Nucl Med; 2022; 25(3):285-296. PubMed ID: 36507885
[TBL] [Abstract][Full Text] [Related]
14. FDG PET/CT in Neurolymphomatosis.
Soni N; Ora M
Radiology; 2021 Jan; 298(1):36. PubMed ID: 33107802
[No Abstract] [Full Text] [Related]
15. Breast Relapse of Pediatric B-Cell Acute Lymphoblastic Leukemia After CAR-T Therapy Detected by
Perrone E; Taralli S; Pagliara D; Larocca LM; Vinti L; Leccisotti L
Anticancer Res; 2024 May; 44(5):2243-2245. PubMed ID: 38677722
[TBL] [Abstract][Full Text] [Related]
16. Primary Central Nervous System Lymphoma With Diffuse Neurolymphomatosis Involving Multiple Cranial and Spinal Nerve Roots.
Singh SS; Mittal BR; Kumar R; Singh H; Balaini N; Goyal M
Clin Nucl Med; 2020 Jun; 45(6):e285-e287. PubMed ID: 32332304
[TBL] [Abstract][Full Text] [Related]
17. Role of FDG PET/CT in Patients With Lymphoma Treated With Chimeric Antigen Receptor T-Cell Therapy: Current Concepts.
Murad V; Kohan A; Ortega C; Prica A; Veit-Haibach P; Metser U
AJR Am J Roentgenol; 2024 Mar; 222(3):e2330301. PubMed ID: 38054958
[TBL] [Abstract][Full Text] [Related]
18. [A case of neurolymphomatosis].
Gelezhe PB; Medvedeva AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8):150-153. PubMed ID: 36036417
[TBL] [Abstract][Full Text] [Related]
19. Editorial Comment: FDG PET/CT Has Impact in Chimeric Antigen Receptor T-Cell Therapy Response Assessment and Outcome Prediction.
Marcus C
AJR Am J Roentgenol; 2024 Mar; 222(3):e2330703. PubMed ID: 38117102
[No Abstract] [Full Text] [Related]
20. Sciatic and median nerve neurolymphomatosis as initial presentation of B-cell lymphoma.
Barahona D; Adlerstein I; Donoso J; Mercado F
Radiologia (Engl Ed); 2022; 64(3):266-269. PubMed ID: 35676058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
